Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Transgenic Organisms00:53

Transgenic Organisms

Overview
What is Genetic Engineering?00:49

What is Genetic Engineering?

Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Transgenic Plants02:50

Transgenic Plants

Recombinant DNA technology called transgenesis is often used to add a foreign gene or remove a detrimental gene from an organism. Such genetically modified organisms are called transgenic organisms.
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antipsychotic Drugs and the Risk of Diabetic Complications: A Systematic Review of Observational Studies.

Journal of clinical medicine·2026
Same author

Understanding how adverse childhood experiences influence the development of postpartum post-traumatic stress disorder: a qualitative study in China.

European journal of psychotraumatology·2026
Same author

Antipsychotic Drugs and the Risk of Diabetic Complications: A Systematic Review of Clinical Evidence.

Journal of clinical medicine·2026
Same author

Effects of vaginal microbiota transfer on social-emotional and neurodevelopment in cesarean-born infants: 12-month follow-up of a pilot randomized clinical trial.

Acta obstetricia et gynecologica Scandinavica·2026
Same author

Self-perceived mental health among Canadian adolescents and young adults with asthma: Insights from a national cross-sectional study.

The Journal of asthma : official journal of the Association for the Care of Asthma·2026
Same author

Trends in Antipsychotic Drug Use in the United States, 2000-2016.

Pharmacy (Basel, Switzerland)·2026

Related Experiment Video

Updated: Jul 2, 2026

The Lambda Select cII Mutation Detection System
07:08

The Lambda Select cII Mutation Detection System

Published on: April 26, 2018

A risk-based classification scheme for genetically modified foods. II: Graded testing.

Eunice Chao1, Daniel Krewski

  • 1McLaughlin Centre for Population Health Risk Assessment, Institute of Population Health, University of Ottawa, 1 Stewart Street, Ottawa, Ont., Canada K1N 6N5. echao@uottawa.ca

Regulatory Toxicology and Pharmacology : RTP
|September 5, 2008
PubMed
Summary
This summary is machine-generated.

This study proposes a risk-based classification scheme for genetically modified (GM) foods, enabling efficient resource allocation for testing. The graded approach prioritizes higher concern GM foods for more extensive safety assessments.

More Related Videos

Transgenic Rodent Assay for Quantifying Male Germ Cell Mutant Frequency
14:45

Transgenic Rodent Assay for Quantifying Male Germ Cell Mutant Frequency

Published on: August 6, 2014

Related Experiment Videos

Last Updated: Jul 2, 2026

The Lambda Select cII Mutation Detection System
07:08

The Lambda Select cII Mutation Detection System

Published on: April 26, 2018

Transgenic Rodent Assay for Quantifying Male Germ Cell Mutant Frequency
14:45

Transgenic Rodent Assay for Quantifying Male Germ Cell Mutant Frequency

Published on: August 6, 2014

Area of Science:

  • Food Science and Technology
  • Biotechnology
  • Risk Assessment

Background:

  • Current genetically modified (GM) food assessment relies on standardized premarket evaluations.
  • There is a need for more efficient and targeted testing strategies for GM foods.
  • Existing testing methods may not cover all potential safety concerns.

Purpose of the Study:

  • To present a graded approach for testing crop-derived genetically modified (GM) foods.
  • To introduce a proposed risk-based classification scheme (RBCS) for GM food assessment.
  • To align testing intensity with varying levels of concern for GM food products.

Main Methods:

  • Development of a risk-based classification scheme (RBCS) with distinct concern levels (Level I, II, III).
  • Categorization of GM foods based on RBCS, determining the extent of required testing.
  • Consideration of factors like substance type, dietary history, exposure, toxicity, and unintended changes for higher-level testing.

Main Results:

  • Level I GM foods require baseline testing, comparable to current premarket assessments, with minimal further analysis.
  • Level II and higher classifications necessitate additional, tailored testing based on specific risk factors.
  • Level III testing focuses on toxic and antinutritional effects of intended changes.

Conclusions:

  • A graded testing approach can optimize the use of resources in GM food safety evaluation.
  • The proposed RBCS provides a framework for tiered testing, focusing on higher-concern GM foods.
  • Further research is needed to develop comprehensive testing methods for all potential GM food safety concerns.